GGT fasting state
Selected indexed studies
- Predictive factors of significant fibrosis in metabolic dysfunction-associated steatotic liver disease. (Tunis Med, 2025) [PMID:41712809]
- Efficacy of Hypoglycemic Agents in Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD): A Systematic Review and Network Meta-Analysis. (J Evid Based Med, 2025) [PMID:40229658]
- [Microvesicular steatosis]. (Rev Med Chir Soc Med Nat Iasi, 2002) [PMID:12638271]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Machine Learning-Based Biomarker Identification for Early Diagnosis of Metabolic Dysfunction-Associated Steatotic Liver Disease. (2025) pubmed
- Correlation between ratio of fasting blood glucose to high density lipoprotein cholesterol in serum and non-alcoholic fatty liver disease in American adults: a population based analysis. (2024) pubmed
- Causal association between type 1 diabetes and autoimmune cholestasis: A bi-directional Mendelian randomized study. (2025) pubmed
- Predictive factors of significant fibrosis in metabolic dysfunction-associated steatotic liver disease. (2025) pubmed
- Longitudinal Analysis of Liver Chemistry Trajectories and Risk of Type 2 Diabetes in Children With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Multicenter Cohort Study. (2026) pubmed
- Association between serum uric acid-to-high-density lipoprotein cholesterol ratio and metabolic dysfunction-associated steatotic liver disease among Chinese children with obesity. (2024) pubmed
- Efficacy of Hypoglycemic Agents in Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD): A Systematic Review and Network Meta-Analysis. (2025) pubmed
- [Microvesicular steatosis]. (2002) pubmed
- Fatty liver indices in the multiethnic United States National Health and Nutrition Examination Survey. (2015) pubmed
- Global testing of shifts in metabolic phenotype. (2018) pubmed